Inhibition of p38 enhances ERK inhibitor efficacy in pancreatic ductal adenocarcinoma

被引：0
|
作者：
Ryan, Meagan B.
Bryant, Kirsten L.
Hayes, Tikvah K.
Kher, Swapnil
Wood, Kris C.
Samatar, Ahmed A.
Cox, Adrienne D.
Der, Channing J.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4660
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4660
引用
收藏
页数：3
相关论文
共 50 条
  • [21] High Expression of P38α and Preoperative Carbohydrate Antigen 19-9 Indicate Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma
    Chen, Jionghuang
    Zhao, Ting
    Jia, Shengnan
    Zhou, Senhao
    Zhou, Liangjing
    Wang, Shaowen
    Ding, Guoping
    Jiang, Guixing
    Cao, Liping
    JOURNAL OF CANCER, 2018, 9 (04): : 650 - 658
  • [22] The Autophagy Inhibitor Verteporfin Moderately Enhances the Antitumor Activity of Gemcitabine in a Pancreatic Ductal Adenocarcinoma Model
    Donohue, Elizabeth
    Thomas, Anitha
    Maurer, Norbert
    Manisali, Irina
    Zeisser-Labouebe, Magali
    Zisman, Natalia
    Anderson, Hilary J.
    Ng, Sylvia S. W.
    Webb, Murray
    Bally, Marcel
    Roberge, Michel
    JOURNAL OF CANCER, 2013, 4 (07): : 585 - 596
  • [23] Regorafenib induces DNA damage and enhances PARP inhibitor efficacy in pancreatic ductal carcinoma
    Pham, Thao D.
    Becker, Jeffrey H.
    Metropulos, Anastasia E.
    Mubin, Nida
    Spaulding, Christina
    Bentrem, David J.
    Munshi, Hidayatullah G.
    BMC CANCER, 2024, 24 (01)
  • [24] Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling
    Xue, Aiqun
    Xue, Meilang
    Jackson, Christopher
    Smith, Ross C.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2009, 41 (8-9): : 1731 - 1738
  • [25] Cxcl-12-cxcr4 inhibition enhances immune response in pancreatic ductal adenocarcinoma
    Garg, Bharti
    Ferrantella, Anthony
    Giri, Bhuwan
    Modi, Shrey
    Sethi, Vrisketan
    Kurtom, Saba
    Banerjee, Sulagna
    Sundaram, Ramakrishnan
    Gilboa, Eli
    Saluja, Ashok
    Dudeja, Vikas
    CANCER RESEARCH, 2018, 78 (13)
  • [26] p38α Mitogen-Activated Protein Kinase Is a Druggable Target in Pancreatic Adenocarcinoma
    Yang, Ling
    Sun, Xiaoting
    Ye, Ying
    Lu, Yongtian
    Zuo, Ji
    Liu, Wen
    Elcock, Adrian
    Zhu, Shun
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [27] A novel RAS inhibitor for pancreatic ductal adenocarcinoma.
    Arshad, Tariq
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E16263 - E16263
  • [28] Disclosure of Erlotinib as a Multikinase Inhibitor in Pancreatic Ductal Adenocarcinoma
    Conradt, Laura
    Godl, Klaus
    Schaab, Christoph
    Tebbe, Andreas
    Eser, Stefan
    Diersch, Sandra
    Michalski, Christoph W.
    Kleeff, Joerg
    Schnieke, Angelika
    Schmid, Roland M.
    Saur, Dieter
    Schneider, Guenter
    NEOPLASIA, 2011, 13 (11): : 1026 - U57
  • [29] The role of p38, JNK, and ERK in pancreatic elastase-induced cytokine production.
    Jaffray, C
    Yang, J
    Norman, J
    GASTROENTEROLOGY, 2000, 118 (04) : A167 - A167
  • [30] Isolinderalactone suppresses pancreatic ductal adenocarcinoma by activating p38 MAPK to promote DDIT3 expression and trigger endoplasmic reticulum stress
    Xu, Dongchao
    Wu, Hao
    Tian, Mengyao
    Liu, Qiang
    Zhu, Yuanling
    Zhang, Hongchen
    Zhang, Xiaofeng
    Shen, Hongzhang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 143
12345